Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

NCT04504955 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.

NCT NCT04504955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Lead sponsor
CorEvitas
Phase
Observational
Overall status
Recruiting
Start date
July 14, 2020
Completion date
December 31, 2100
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis